$7.57
-0.03(-0.39%)
Mkt Cap $201M
$5.65
$10.96
52-Week Range
At A Glance
1
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology.
2
Most recently: . Results of Operations and Financial Condition. On February 11, 2026, Nuvectis Pharma, Inc. issued a press release to provide a corporate update and to announc (2026-02-11).
$201M
Market Cap
—
Revenue
-$32M
Net Income
Employees13
Fundamentals
How The Business Makes Money
Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src and YES1 kinases. The company was incorporated in 2020 and is based in Fort Lee, New Jersey.
Industry Biotechnology
Activity
Analyst View
Company Profile
CIK0001875558
ISINUS67080T1088
CUSIP67080T108
Phone201 614 3150
Address1 Bridge Plaza, Fort Lee, NJ, 07024, US
SEC EDGAR